Guest Blog by Neil Betteridge, co-chair, Chronic Pain Policy Coalition (CPPC)
As a former Chair of ARMA, it’s a great pleasure to be invited to write a piece for this month’s newsletter. Indeed, looking back to my seven years on the board, it is quite something to recall that the organisation entered the 21st century still called BLAR: the British League Against Rheumatism.
Apart from the name, much has changed in the world of rheumatic and musculoskeletal diseases since then, most of it for the better in my view.…
Read more of this article
Did you miss getting to the Rheumatology Conferences in 2016?
It’s been another productive month here at ARMA as I pass the three months in post milestone. With such a range of different activities there is never a dull moment. I have just attended my first ARMA Policy and Communications meeting. I enjoyed the lively discussions about joint messages on the importance of self-management and developing a co-ordinated social media plan for Bone and Joint Week in October. There is a lot of potential to support each other to have a bigger impact during the week.… 
On Monday 8th May 2017 the Scottish Medicines Consortium (SMC) published new advice accepting the restricted use of belimumab (Benlysta) by NHS Scotland for lupus patients. This advice was published following a re-submission with evidence supplied by GlaxoSmithKline (the producers of Benlysta) and LUPUS UK on behalf of patients.
The Faculty of Sport and Exercise Medicine (FSEM) UK has published a set of key messages to guide associated organisations and colleges through the specialty of Sport and Exercise Medicine’s work and relevance to MSK Medicine.
BASEM Revision Course for the FSEM Membership Exam: Part 1
The 4th BASEM/FSEM Annual Sport and Exercise Medicine Conference in conjunction with the University of Bath and Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis.
